TECFX
Price
$16.84
Change
+$0.01 (+0.06%)
Updated
Nov 26 closing price
Net Assets
3.37B
VCLAX
Price
$11.51
Change
+$0.01 (+0.09%)
Updated
Nov 26 closing price
Net Assets
5.81B
Interact to see
Advertisement

TECFX vs VCLAX

Header iconTECFX vs VCLAX Comparison
Open Charts TECFX vs VCLAXBanner chart's image
American Funds Tax-Exempt Fund of CA F1
Price$16.84
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets3.37B
Vanguard CA Long-Term Tax-Exempt Adm
Price$11.51
Change+$0.01 (+0.09%)
VolumeN/A
Net Assets5.81B
TECFX vs VCLAX Comparison Chart in %
View a ticker or compare two or three
VS
TECFX vs. VCLAX commentary
Nov 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TECFX is a Hold and VCLAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VCLAX has more cash in the bank: 5.81B vs. TECFX (3.37B). VCLAX pays higher dividends than TECFX: VCLAX (3.49) vs TECFX (2.91). TECFX was incepted earlier than VCLAX: TECFX (25 years) vs VCLAX (24 years). TECFX (0.66) is less costly to investors than VCLAX (0.09). TECFX has a lower initial minimum investment than VCLAX: TECFX (1000) vs VCLAX (50000). TECFX annual gain was more profitable for investors over the last year : 0.05 vs. VCLAX (-0.61). TECFX return over 5 years is better than : -7.36 vs. VCLAX (-10.29).
TECFXVCLAXTECFX / VCLAX
Total Expense Ratio0.660.09733%
Annual Report Gross Expense Ratio0.660.09733%
Fund Existence25 years24 years-
Gain YTD0.8380.524160%
Front LoadN/AN/A-
Min. Initial Investment1000500002%
Min. Initial Investment IRAN/AN/A-
Net Assets3.37B5.81B58%
Annual Yield % from dividends2.913.4983%
Returns for 1 year0.05-0.61-8%
Returns for 3 years4.984.32115%
Returns for 5 years-7.36-10.2972%
Returns for 10 years-1.81-4.5840%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMGCX24.89N/A
N/A
BlackRock Mid-Cap Growth Equity Inv C
IIVAX27.93N/A
N/A
Transamerica Small/Mid Cap Value A
TVRCX16.43N/A
N/A
NAA Allocation C
LMNOX51.55N/A
N/A
Patient Opportunity I
RYZAX119.05N/A
N/A
Rydex S&P 500 Pure Value H